Gapping up
In reaction to earnings/guidance:
- PPG +4.1%, MATX +3.8%, AA +3.2%, JBHT +1.9%, ALLY +1.9%, BK +1%, STT +1%
M&A news:
- GFN +54.8% (to be acquired by United Rentals (URI) for $19/share), ALXN +4.6% (Astrazenca received US clearance of proposed acquisition of the Co)
Other news:
- PGNY +7% (to join S&P MidCap 400)
- UFS +6.9% (to join S&P SmallCap 600)
- LSCC +6.9% (to join S&P MidCap 400)
- TGTX +6.9% (announces positive results from the ULTIMATE I & II Phase 3 trials of ublituximab in multiple sclerosis)
- DKNG +4.7% (to become an Official Sports Betting Partner of the NFL)
- BTX +4.3% (pays $1 mln towards acquisition of license for mRNA technology platform),
- DMTK +3.3% (announces topline results from its second economic study of PLA), SYBX +2.5% (stock offering),
- IDYA +1.6% (announces investor day to review data from Phase 1/2 Trial of Darovasertib)
- REGI +1.5% (names new CFO)
- KSU +1.4% (announces that Jeffrey Songer has been named to a new position as executive vice president - strategic merger planning and John Orr has been named executive vice president - operations)
- PTC +1.3% (to join S&P 500)
Analyst comments:
- IOVA +9.2% (initiated with a Buy at Goldman)
- WIT +5.2% (upgraded to Buy from Neutral at Citi)
- ARRY +3.8% (upgraded to Buy from Neutral at UBS)
- DRNA +3.4% ( initiated with a Buy at Goldman)
- RUN +3.1% (upgraded to Overweight from Neutral at Piper Sandler)
- UBA +2.7% (upgraded to Overweight from Neutral at Piper Sandler)
- WKHS +2.3% (initiated with a Buy at B. Riley Securities)
- MITK +1.8% (initiated with a Buy at Jefferies)
- MPC +1.7% (upgraded to Strong Buy from Mkt Perform at Raymond James)
- JKS +1.4% (upgraded to Neutral from Sell at UBS)
- OSK +1.4% (upgraded to Buy from Neutral at UBS)
- SPG +1.4% (upgraded to Buy from Hold at Jefferies)
- AAWW +1.4% (initiated with a Buy at Truist)
- CMCSA +1.3% (upgraded to Outperform from Mkt Perform at Raymond James)
- AFRM +1.2% (upgraded to Buy from Neutral at Seaport Global Securities)
- BLDP +1.2% (initiated with a Buy at B. Riley Securities)
- CSCO +1.2% (upgraded to Outperform from Peer Perform at Wolfe Research)